5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Economic Costs of Diseases and Deaths Attributable to Tobacco Use in India, 2017–2018

      1 , 2 , 2 , 2
      Nicotine & Tobacco Research
      Oxford University Press (OUP)

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          About 28.6% of Indian adults use tobacco. This study estimates the economic burden of deaths and diseases attributable to smoking and smokeless tobacco (SLT) use for persons aged ≥35 years.

          Methods

          The National Sample Survey data on healthcare expenditures, the Global Adult Tobacco Survey data on tobacco use prevalence, and relative risks of all-cause mortality from tobacco use were used to estimate the economic burden of diseases and deaths attributable to tobacco use in India, using a prevalence-based attributable-risk approach. Costs are estimated under the following heads: (1) direct medical and nonmedical expenditures; (2) indirect morbidity costs; and (3) indirect mortality costs of premature deaths.

          Results

          Total economic costs attributable to tobacco use from all diseases and deaths in India in the year 2017–2018 for persons 35 years or older amount to INR 1773.4 billion (US $27.5 billion), of which 22% is direct and 78% is indirect cost. Men bear 91% of the total costs. Smoking contributed 74% and SLT use contributed 26% of the costs.

          Conclusions

          The economic costs of tobacco use amount to approximately 1.04% of India’s gross domestic product (GDP), while the excise tax revenue from tobacco in the previous year was only 12.2% of its economic costs. The direct medical costs alone amount to 5.3% of total health expenditure. The enormous costs imposed on the nation’s health care system due to tobacco use could potentially stress the public health care system and strain the economy and it warrants massive scaling up of tobacco control efforts in India.

          Implications

          The study finds that the economic burden from tobacco constitutes more than 1% of India’s GDP, and the direct health expenditures on treating tobacco-related diseases alone accounts for 5.3% of the total private and public health expenditures in India in a year. It shows that, for every INR 100 that is received as excise taxes from tobacco products, INR 816 of costs is imposed on society through its consumption. It establishes that tobacco consumption is a major resource drain on the national exchequer, and its effective regulation through comprehensive fiscal and non-fiscal policies is highly warranted.

          Related collections

          Author and article information

          Contributors
          Journal
          Nicotine & Tobacco Research
          Oxford University Press (OUP)
          1469-994X
          February 01 2021
          January 22 2021
          August 17 2020
          February 01 2021
          January 22 2021
          August 17 2020
          : 23
          : 2
          : 294-301
          Affiliations
          [1 ]Health Economist and Independent Researcher, Kerala, India
          [2 ]World Health Organization India Country Office, New Delhi, India
          Article
          10.1093/ntr/ntaa154
          32805055
          7caa86d5-18f3-4564-ba56-9d703a696b16
          © 2020

          https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

          History

          Comments

          Comment on this article